Showing results (1-10 of 321) with videos related to
Sort By:
Pageof 33
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Pharmacogenomic contribution to drug responseRoshawn G Watson, Howard L McLeodClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2005
Pharmacogenetic analysis of clinically relevant genetic polymorphismsHoward L McLeodExpert Review of Anticancer Therapy|July 13, 2002
Individualized cancer therapy: molecular approaches to the prediction of tumor responseHoward L McLeodScience (New York, N.Y.)|March 30, 2013
Cancer pharmacogenomics: early promise, but concerted effort neededHoward L McLeodEuropean Journal of Cancer (Oxford, England : 1990)|August 24, 2010
Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapyRoshawn G Watson, Filipe Muhale, Leigh B Thorne, et al.Expert Opinion on Pharmacotherapy|January 30, 2007
Pharmacogenetics and oncology treatment for breast cancerSharon Marsh, Howard L McLeodCancer Investigation|October 10, 2003
Cancer pharmacogenomics: SNPs, chips, and the individual patientHoward L McLeod, Jinsheng YuAnti-Cancer Drugs|August 13, 2005
PI3K/Akt/mTOR pathway as a target for cancer therapyDaniel Morgensztern, Howard L McLeodPharmacogenomics|April 23, 2002
The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomicsHoward L McLeod, Chokkalingam SivaCancer Journal (Sudbury, Mass.)|October 4, 2005
Pharmacogenetics and pediatric cancerLisa Bomgaars, Howard L McLeodPageof 33